ENTERA BIO LTD's ticker is ENTXW and the CUSIP is M40527117. A total of 4 filers reported holding ENTERA BIO LTD in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $40,000 | -51.2% | 284,914 | -5.9% | 0.03% | -17.5% |
| Q2 2020 | $82,000 | +54.7% | 302,644 | +8.2% | 0.04% | +53.8% |
| Q4 2019 | $53,000 | +657.1% | 279,819 | +1815.8% | 0.03% | +550.0% |
| Q3 2019 | $7,000 | +16.7% | 14,606 | +4.1% | 0.00% | +33.3% |
| Q2 2019 | $6,000 | -53.8% | 14,030 | +0.6% | 0.00% | -57.1% |
| Q1 2019 | $13,000 | – | 13,943 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DLD Asset Management, LP | 310,023 | $279,000 | 0.01% |
| Worth Venture Partners, LLC | 13,943 | $13,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 4,393 | $1,000 | 0.00% |